| Suven Life Sciences Ltd | Industry : (Healthcare) | |
|---|---|---|
|
BSE Code : 530239 |
NSE Symbol : SUVEN |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE495B01038 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : 47.01 |
Market Cap(₹Cr) : 3,888.67 |
Face Value(₹) : 1.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 0.92 | 1.87 | 1.47 | 1.61 | 2.57 | 1.01 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 0.92 | 1.87 | 1.47 | 1.61 | 2.57 | 1.01 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 3.78 | 0.59 | 1.19 | 1.57 | 4.03 | 3.93 |
| Total Income | 4.70 | 2.46 | 2.66 | 3.18 | 6.61 | 4.94 |
| Total Expenditure | 18.83 | 15.87 | 16.38 | 14.91 | 16.21 | 11.09 |
| PBIDT | -14.13 | -13.41 | -13.72 | -11.73 | -9.60 | -6.16 |
| Interest | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | 0.02 |
| PBDT | -14.13 | -13.41 | -13.72 | -11.74 | -9.62 | -6.18 |
| Depreciation | 1.32 | 1.37 | 1.35 | 1.53 | 1.46 | 1.49 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | -15.45 | -14.78 | -15.07 | -13.27 | -11.07 | -7.67 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | -15.45 | -14.78 | -15.07 | -13.27 | -11.07 | -7.67 |
| EPS (Unit Curr.) | -0.70 | -0.68 | -0.69 | -0.61 | -0.51 | -0.35 |
| EPS (Adj) (Unit Curr.) | -0.70 | -0.68 | -0.69 | -0.61 | -0.51 | -0.35 |
| Calculated EPS (Unit Curr.) | -0.68 | -0.68 | -0.69 | -0.61 | -0.51 | -0.35 |
| Calculated EPS (Adj) (Unit Curr.) | -0.68 | -0.68 | -0.69 | -0.61 | -0.51 | -0.35 |
| Calculated EPS (Ann.) (Unit Curr.) | -2.72 | -2.71 | -2.76 | -2.43 | -2.03 | -1.41 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | -2.72 | -2.71 | -2.76 | -2.43 | -2.03 | -1.41 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 22.75 | 21.81 | 21.81 | 21.81 | 21.81 | 21.81 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | -1,535.87 | -717.11 | -933.33 | -728.57 | -373.54 | -609.90 |
| PBDTM(%) | -1,535.87 | -717.11 | -933.33 | -729.19 | -374.32 | -611.88 |
| PATM(%) | -1,679.35 | -790.37 | -1,025.17 | -824.22 | -430.74 | -759.41 |